| Dr Jeffry Raymond Peterson, DO | |
|
116 E 11th St, Suite 101, Spencer, IA 51301-4364 | |
| (712) 264-3500 | |
| (712) 264-3535 |
| Full Name | Dr Jeffry Raymond Peterson |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 116 E 11th St, Spencer, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730169962 | NPI | - | NPPES |
| 3196287 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01768 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffry Raymond Peterson, DO 116 E 11th St, Suite 101, Spencer, IA 51301-4364 Ph: (712) 264-3500 | Dr Jeffry Raymond Peterson, DO 116 E 11th St, Suite 101, Spencer, IA 51301-4364 Ph: (712) 264-3500 |
News Archive
To protect us from disease our immune system employs macrophages, cells that roam our body in search of disease-causing bacteria. With the help of long tentacle-like protrusions, macrophages can catch suspicious particles, pull them towards their cell bodies, internalise and destroy them.
Prescott Group Capital Management, a greater than 10% shareholder of PharmAthene, Inc. (NYSE MKT: PIP), urges all stockholders to vote AGAINST the issuance of shares needed to complete the proposed merger with Theraclone Sciences, Inc. and AGAINST giving PharmAthene the right to adjourn the upcoming special meeting.
Cerus Corporation announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System for platelets and plasma during a leading international transfusion safety meeting, the XIIth International Haemovigilance Seminar taking place in Dubrovnik, Croatia from February 17 to 19.
Poor women and African Americans with ovarian cancer are less likely to receive the highest standards of care, leading to worse outcomes than among white and affluent patients, according to a study of 50,000 women presented by UC Irvine's Dr. Robert Bristow at the Society of Gynecologic Oncology's annual meeting March 27.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
› Verified 7 days ago
Amy C Jochims, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St Ste 101, Spencer, IA 51301 Phone: 712-264-3581 Fax: 712-264-3509 | |
Travis J. Witt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 | |
Dr. David Paul Robison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. John Edwin Hilsabeck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. Ronald James Creswell, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. Sonia Albertson Sather, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. Amanda E Young, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 |